Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer

Michael A. Carducci, Luna Musib, Merrill S. Kies, Roberto Pili, Mylene Truong, Julie R. Brahmer, Patricia Cole, Rana Sullivan, Jeanne Riddle, Jill Schmidt, Nathan Enas, Vikram Sinha, Donald E. Thornton, Roy S. Herbst

Research output: Contribution to journal › Article › peer-review

167 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences